Free Access
Issue
Biologie Aujourd’hui
Volume 216, Number 3-4, 2022
Page(s) 125 - 130
DOI https://doi.org/10.1051/jbio/2022013
Published online 6 février 2023
  • Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., Sirigu, A. (2010). Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA, 107, 4389-4394. [CrossRef] [PubMed] [Google Scholar]
  • Becker, J.A., Clesse, D., Spiegelhalter, C., Schwab, Y., Le Merrer, J., Kieffer, B.L. (2014). Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity. Neuropsychopharmacology, 39, 2049-2060. [CrossRef] [PubMed] [Google Scholar]
  • Carter, C.S., Getz, L.L. (1993). Monogamy and the prairie vole. Sci Am, 268, 100-106. [CrossRef] [PubMed] [Google Scholar]
  • Chini, B., Mouillac, B., Ala, Y., Balestre, M.N., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M., Manning, M., Jard, S., Barberis, C. (1997). Identification of a single residue responsible for agonist selectivity in the Oxytocin–Vasopressin receptors. Ann NY Acad Sci, 812, 218-221. [CrossRef] [PubMed] [Google Scholar]
  • Danoff, J.S., Wroblewski, K.L., Graves, A.J., Quinn, G.C., Perkeybile, A.M., Kenkel, W.M., Lillard, T.S., Parikh, H.I., Golino, H.F., Gregory, S.G., Carter, C.S., Bales, K.L., Connelly, J.J. (2021). Genetic, epigenetic, and environmental factors controlling oxytocin receptor gene expression. Clin Epigenetics, 13, 23. [CrossRef] [PubMed] [Google Scholar]
  • Frantz, M.C., Rodrigo, J., Boudier, L., Durroux, T., Mouillac, B., Hibert, M. (2010). Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist. J Med Chem, 53, 1546-1562. [CrossRef] [PubMed] [Google Scholar]
  • Frantz, M.C., Pellissier, L.P., Pflimlin, E., Loison, S., Gandía, J., Marsol, C., Durroux, T., Mouillac, B., Becker, J.A.J., Le Merrer, J., Valencia, C., Villa, P., Bonnet, D., Hibert, M. (2018). LIT-001, the first nonpeptide oxytocin receptor agonist that improves social interaction in a mouse model of autism. J Med Chem, 61, 8670-8692. [CrossRef] [PubMed] [Google Scholar]
  • Freund-Mercier, M.J., Ocytocine : entre mythe et réalité, Doin Ed., Paris, 2022. [Google Scholar]
  • Hibert, M., Trumpp-Kallmeyer, S., Bruinvels, A., Hoflack, J. (1991). Three-dimensional models of the cationic neurotransmitter G-protein coupled receptors. Mol Pharmacol, 40, 8-15. [PubMed] [Google Scholar]
  • Hibert, M., Trumpp-Kallmeyer, S., Bruinvels, A., Hoflack, J. (1993). This is not a G protein-coupled receptor. Trends Pharmacol Sci, 14, 7-12. [CrossRef] [PubMed] [Google Scholar]
  • Hibert, M., Hoflack, J., Trumpp-Kallmeyer, S., Paquet, J.L., Leppik, R., Barberis, C., Mouillac, B., Chini, B., Jard, S. (1995). 3D models of hormone receptors: experimental validation. Eur J Med Chem, 30, 189-199. [Google Scholar]
  • Hibert, M., Hoflack, J., Trumpp-Kallmeyer, S., Mouillac, B., Chini, B., Mahé, E., Cotte, N., Jard, S., Manning, M., Barberis, C. (1999). Functional architecture of vasopressin/oxytocin receptors. J Recept Signal Transduct Res, 19, 589-596. [CrossRef] [PubMed] [Google Scholar]
  • Hibert, M., Ocytocine mon amour, HumenSciences Ed., Paris, 2021. [Google Scholar]
  • Hicks, C., Ramos, L., Reekie, T., Narlavar, R., Kassiou, M., McGregor, L. (2015). WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action. Psychopharmacology, 232, 2659-2667. [CrossRef] [PubMed] [Google Scholar]
  • Hilfiger, L., Zhao, Q., Kerspern, D., Inquimbert, P., Andry, V., Goumon, Y., Darbon, P., Hibert, M., Charlet, A. (2020). A nonpeptide oxytocin receptor agonist for a durable relief of inflammatory pain. Sci Rep, 10, 3017. [CrossRef] [PubMed] [Google Scholar]
  • Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C.M., Aronowitz, B.R. (2003). Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger’s disorders. Neuropsychopharmacology, 28, 193-198. [CrossRef] [PubMed] [Google Scholar]
  • Karpenko, I.A., Margathe, J.F., Rodriguez, T., Pflimlin, E., Dupuis, E., Hibert, M., Durroux, T., Bonnet, D. (2015). Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay. J Med Chem, 58, 2547-2552. [CrossRef] [PubMed] [Google Scholar]
  • Meyerowitz, J., Robertson, M., Ximena Barros-Álvarez, X., Panova, O., Nwokonko, R., Gao, Y., Skiniotis, G. (2022). The oxytocin signaling complex reveals a molecular switch for cation dependence. Nat Struct Mol Biol, 29, 274-281. [CrossRef] [PubMed] [Google Scholar]
  • Mouillac, B., Chini, B., Balestre, M.N., Jard, S., Barberis, C., Manning, M., Tribollet, E., Trumpp-Kallmeyer, S., Hoflack, J., Elands, J., Hibert, M. (1995). Identification of agonist binding sites of vasopressin and oxytocin receptors. Adv Exp Med Biol, 395, 301-310. [PubMed] [Google Scholar]
  • Phalipou, S., Seyer, R., Cotte, N., Barberis, C., Hibert, M., Mouillac, B. (1999). Docking of linear peptide antagonists into the human V1a vasopressin receptor: identification of binding domains by photoaffinity. J Biol Chem, 274, 23316-23327. [CrossRef] [PubMed] [Google Scholar]
  • Pitt, G.R., Batt, A.R., Haigh, R.M., Penson, A.M., Robson, P.A., Rooker, D.P., Tartar, A.L., Trim, J.E., Yea, C.M., Roe, M.B. (2004). Nonpeptide oxytocin agonists. Bioorg Med Chem Lett, 14, 4585-4589. [CrossRef] [PubMed] [Google Scholar]
  • Rahman, Z., Resnick, L., Rosenzweig-Lipson, S.J., Ring, R.H. (2007). Methods of treatment using oxytocin receptor agonists. US patent application 2007/0117794 (published 2007-05-24). [Google Scholar]
  • Tahtaoui, C., Balestre, M.N., Klotz, P., Rognan, D., Barberis, C., Mouillac, B., Hibert, M. (2003). Identification of the binding sites of the SR 49059 nonpeptide antagonist into the V1a vasopressin receptor using sulfydryl-reactive ligands and cysteine mutants as chemical sensors. J Biol Chem, 278, 40010-40019. [CrossRef] [PubMed] [Google Scholar]
  • Trumpp-Kallmeyer, S., Bruinvels, J.A., Hibert, M. (1992) Modelling of G-protein coupled receptors: application to dopamine, serotonin, adrenaline, acetylcholine and mammalian opsin receptors. J Med Chem, 35, 3448-3462. [CrossRef] [PubMed] [Google Scholar]
  • Waltenspühl, Y., Schöppe, J., Ehrenmann, J., Kummer, L., Plückthun, A. (2020). Crystal structure of the human oxytocin receptor. Sci Adv, 15, 6, eabb5419. [CrossRef] [PubMed] [Google Scholar]
  • Williams, J.R., Insel, T.R., Harbaugh, C.R., Carter, C.S. (1994). Oxytocin administered centrally facilitates formation of a partner preference in female prairie voles (Microtus ochrogaster). J Neuroendocrinol, 6, 247-250. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.